Myriad Genetics Inc (NASDAQ:MYGN)

35.87
Delayed Data
As of May 25
 -0.07 / -0.19%
Today’s Change
19.75
Today|||52-Week Range
41.57
+4.44%
Year-to-Date

Today’s Trading

Previous close35.94
Today’s open35.88
Day’s range35.58 - 36.09
Volume314,578
Average volume (3 months)711,797
Market cap$2.4B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)+13.97%
Earnings growth (next 5 years)+12.12%
Revenue growth (last year)+2.33%
P/E ratio18.6
Price/Sales2.30
Price/Book3.03

Competitors

----
NEOGNeogen Corp-0.14-0.19%
IMMUImmunomedics Inc+0.20+0.89%
QDELQuidel Corp-0.70-1.13%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)$0.33
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts